Examples of 'biogen idec' in a sentence
Meaning of "biogen idec"
biogen idec: Biogen Idec was a biotechnology company that focused on developing therapies for neurological and autoimmune disorders. It was known for its research in areas such as multiple sclerosis, hemophilia, and oncology. The company has since rebranded as Biogen, following a merger with Idec Pharmaceuticals
How to use "biogen idec" in a sentence
Basic
Advanced
biogen idec
Biogen Idec had just such a drug in development.
Tysabri was developed and is being marketed in collaboration with Biogen Idec.
Biogen Idec is the oldest independent biotechnology company in the world.
These statements are based on the current expectations of Biogen Idec management.
Biogen Idec is developing daclizumab in collaboration with Abbott.
The study was supported by Biogen Idec.
Biogen Idec will have full ownership and control of Tysabri.
Several authors disclosed financial ties to Biogen Idec.
Biogen Idec is also sponsoring two symposia during the Congress.
It was funded in part by Biogen Idec.
Biogen Idec has several programs underway in ALS.
It is in development by Biogen Idec.
Biogen Idec has recently.
TECFIDERA will mark the fourth therapy Biogen Idec offers people living with MS.
Biogen Idec intends to appeal this opinion and request a re-examination.
See also
Portola retains an option to co-promote alongside Biogen Idec in the US in major indications.
Biogen Idec creates new standards of care in oncology, neurology and immunology.
Under the terms of the collaboration, Biogen Idec and Cardiokine expect to jointly develop lixivaptan.
If Biogen Idec exercises its option, it will assume global development, regulatory and commercialization responsibilities.
Avonex ® is a registered trademark of Biogen Idec Inc.
I joined Biogen Idec f ive years ago to lead the development of long-lasting coagulat ion factors.
Previous PostSolidarity WalkNext Post Biogen Idec has new positive data from Tecfidera ® in MS.
Biogen Idec multiple sclerosis and hemophilia therapies - Asia.
It is under development by Hoffmann-La Roche 's subsidiary Genentech, and Biogen Idec.
Based on these results, Biogen Idec has discontinued development of dexpramipexole in ALS.
Douglas Williams, Ph.D., executive vice president of Research and Development at Biogen Idec.
Biogen Idec has new positive data from Tecfidera ® in MS.
Tysabri is the most effective MS medicine available, generating $1.1 billion annually for Biogen Idec.
It is co-marketed by Biogen Idec and Élan as Tysabri, and was previously named Antegren.
Biogen Idec and AbbVie plan to file for marketing approval in 2015.
Organizationally, Biogen Idec will reduce its headcount by approximately 13 %.
Biogen Idec retains full worldwide commercial rights to BG-12.
You'll also be interested in:
Examples of using Biogen
Show more
Biogen reported results in line with expectations
These fuels are also referred to as biogen fuels
Biogen strives to be a pioneer in the research and
